Exclusive

Publication

Byline

Velos to accelerate medical innovation in Monash Technology Precinct in Australia

Singapore, Aug. 22 -- A new Monash Technology Precinct accelerator focussing on cardiovascular, kidney and metabolic diseaseswill help transform medical innovation ideas into reality. Monash Velos Ac... Read More


Australia develops new AI tool to rapidly diagnose skin cancer

Singapore, Aug. 21 -- A new artificial intelligence (AI) tool developed at the University of Melbourne is helping transform how skin cancer is detected. The technology has the potential to save lives,... Read More


Korea's Avixgen inks agreement worth $360 M with US biotech firm for next-gen drug delivery platform

Singapore, Aug. 19 -- Avixgen, a subsidiary of South Korea-based Dx&Vx, has signed a licensing-out agreement worth approximately $360 million with a US biotechnology company for its next-generation dr... Read More


Nicox and Kowa sign €191.5 M deal for glaucoma treatment

Singapore, Aug. 19 -- Paris-based Nicox SA, an international ophthalmology company, has announced the signing of a major new agreement concerning NCX 470 with Kowa Company, a Japanese company with a g... Read More


Monash University to build Australian-first supercomputer MAVERIC with global technology partners

Singapore, Aug. 19 -- Monash University is developing and deployingMAVERIC, in collaboration with NVIDIA, Dell Technologies and the CDC Data Centres (CDC). The advanced artificial intelligence (AI) su... Read More


Singapore approvesBeyfortus(R) (nirsevimab) to protect all infants against RSV disease

Singapore, Aug. 19 -- The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca's BEYFORTUS (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract d... Read More


2nd World Companion Diagnostics & Liquid Biopsy Summit APAC | November 12-13, 2025 | Singapore

Singapore, Aug. 19 -- Uniting 100+ precision medicine leaders from biopharma, diagnostic development, regulation, and healthcare institutes, the 2nd World Companion Diagnostics & Liquid Biopsy Summit ... Read More


Korea's GC Biopharma signs MoU with Thai Red Cross Society to strengthen collaboration on plasma-derived therapies

Singapore, Aug. 18 -- GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training f... Read More


Skyhawk Therapeutics inks $2 B deal with Merck to discover novel RNA-targeting small molecules for neurological disorders

Singapore, Aug. 18 -- US-based startup Skyhawk Therapeutics, Inc., a leader in the discovery and development of small molecules that modulate RNA expression, has announced a strategic research collabo... Read More


Japan's Eisai launches in-house developed anti-insomnia drug DAYVIGO(R) (Lemborexant) in China

Singapore, Aug. 18 -- Eisai Co. has announced that the in-house discovered and developed orexin receptor antagonist DAYVIGO(R) (brand name in China: "DAYVIGO(R)" generic name: lemborexant) has launche... Read More